On the basis of our in vivo and in vitro co-culture and EET-supplementation experiments, we hypothesized that inhibiting FABP4 and FABP5 is critical in attenuating EET-driven TNBC tumor growth, relapse, and metastasis. Here, FABP5 is linked to neoplasm.